RDY
Dr. Reddy's Laboratories Ltd
$13.52
-$0.06(-0.44%)
55
Overall
70
Value
54
Tech
42
Quality
Market Cap
$11.47B
Volume
1.48M
52W Range
$12.19 - $16.17
Target Price
$15.50
Order:
Income Statement
| Metric | Trend | Chart | 2024 Mar | 2025 Mar |
|---|---|---|---|---|
| REVENUE | ||||
| Total Revenue | $279.2B | $325.5B | ||
| Total Revenue | $279.2B | $325.5B | ||
| COST OF GOODS SOLD | ||||
| Cost of Revenue | $115.6B | $135.1B | ||
| GROSS PROFIT | ||||
| Gross Profit | $163.6B | $190.4B | ||
| OPERATING EXPENSES | ||||
| Operating Expenses | $95.9B | $116.9B | ||
| Research & Development | $22.9B | $27.4B | ||
| Research Expense | $22.9B | $27.4B | ||
| Selling, General & Administrative | $77.2B | $93.9B | ||
| Selling & Marketing Expenses | $77.2B | $93.9B | ||
| Other Operating Expenses | $-4.2B | $-4.4B | ||
| OPERATING INCOME | ||||
| Operating income | $67.7B | $73.5B | ||
| EBITDA | $88.4B | $96.7B | ||
| NON-OPERATING ITEMS | ||||
| Interest Expense (Non-Operating) | $1.7B | $2.8B | ||
| Intinc | $5.7B | $7.6B | ||
| Net Non-Operating Interest Income/Expense | $4.0B | $4.7B | ||
| Other Income/Expense | $-147.0M | $-217.0M | ||
| SPECIAL ITEMS | ||||
| Special Income Charges | $-3.0M | $-1.7B | ||
| Impairment of Capital Assets | $3.0M | $1.7B | ||
| PRE-TAX INCOME | ||||
| EBIT | $73.6B | $79.6B | ||
| Pre-Tax Income | $71.9B | $76.8B | ||
| INCOME TAX | ||||
| Tax Provision | $16.2B | $20.2B | ||
| NET INCOME | ||||
| Net Income | $55.7B | $56.5B | ||
| Net Income (Continuing Operations) | $55.7B | $56.5B | ||
| Net Income (Discontinued Operations) | $55.7B | $56.5B | ||
| Net Income (Common Stockholders) | $55.7B | $56.5B | ||
| Normalized Income | $71.2B | $77.7B | ||
| TOTALS | ||||
| Total Expenses | $211.4B | $252.0B | ||
| SHARE & EPS DATA | ||||
| Average Shares Outstanding | $832.0M | $833.0M | ||
| Average Shares Outstanding (Diluted) | $833.5M | $834.2M | ||
| Shares Outstanding | $834.5M | $834.5M | ||
| Basic EPS | $66.93 | $67.88 | ||
| Basic EPS (Continuing Operations) | $66.93 | $67.88 | ||
| Diluted EPS | $66.8 | $67.78 | ||
| Diluted EPS (Continuing Operations) | $66.8 | $67.78 | ||
| Dividend Per Share | $0.48 | -- | ||
| OTHER METRICS | ||||
| Earnings from equity interest | $147.0M | $217.0M | ||
| Earnings From Equity Interest Net Of Tax | $147.0M | $217.0M | ||
| Other Costof Revenue | $115.6B | $135.1B | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RDY | $13.52 | -0.4% | 1.48M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Dr. Reddy's Laboratories Ltd Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW